Tempest Therapeutics Inc (TPST) — Capital Reinvestment Ratio

Latest as of June 2021: 0.55x

Tempest Therapeutics Inc (TPST) has a Capital Reinvestment Ratio of 0.55x as of June 2021, meaning it reinvests 1% of its operating cash flow ($127.00K) in capital expenditures ($70.00K). See Tempest Therapeutics Inc net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.55x

Capex / Operating Cash Flow

Operating Cash Flow

$127.00K

USD

Capital Expenditures

$70.00K

USD

Data as of

Jun 2021

Most recent filing

Annual Capital Reinvestment Ratio for Tempest Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Tempest Therapeutics Inc from None to None. For live market cap and broader valuation context, see market value of Tempest Therapeutics Inc.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow